BioTech Medics has announced that they have entered into a wholesaler Distribution Agreement for BioTech’s patented and exclusive Shban Antimicrobial Hand Sanitizer Products with a Dubai distributor.
The initial income and fees to BioTech for 2009 for the Dubai Distributorship is $58,800 and projected $2,000,000 in sales for 2010.
The company said that Shban is protected under US Letters of Patent 5514808, 5574050, 5679711 and 5585391 and a patent pending for the US and international patent. BioTech is seeking and negotiating US and foreign distributorships at the time and will be announcing more foreign distributorships soon.
Shban, in previous in vitro and in vivo testing, has been evaluated for its antimicrobial properties against Staph Aureus, Staph Epidermidis, EC Faecalis, E Coli and Ps Aeruginosa.
BioTech has recently commenced independent clinical testing of Shban Hand Sanitizer Solution to determine if it reduces (or kills) the H1N1 (Swine) Influenza A virus.